Study will use innovative technology to focus on neurodegenerative diseases
Todd McDevitt becomes program director and co-chair of the executive committee
Scott explains how his scientist parents worried he was too interested in science as a child. But that didn’t stop him from declaring he wanted to be a scientist as early as preschool.
New study explains what happens when the immune system ages
Study may lead to new treatments for diseases like multiple sclerosis
Olivia shares how the HIV epidemic in Africa inspired and compelled her to pursue HIV research.
Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain
Scientists receive $8.5M in funding to accelerate progress towards a cure for HIV
Scientists develop a cheaper, quicker, and more reliable stem cell–based technology to facilitate drug discovery
The term begins on January 1, 2018
Sarah shares how summers spent by the ocean piqued her interest in science.
A new center at Gladstone aims to find unforeseen uses for existing drugs
7 Tips to Help Postdocs Transition to the Next Phase of Their Career
Gladstone director is selected as a Bay Area innovator
An unexpected collaboration leads to the discovery of an early predictor of IBD
Bruce describes how his wish to delve deeper into problems and fascination with the potential to discover new biology led him to a career in science.
A single drug could attack the virus on two fronts
The discovery could improve treatments for autoimmune diseases and cancer
Krystal describes how extraordinary mentors led her to graduate school and inspired her to encourage future scientists to pursue an exciting and rewarding career.
Simon takes on a central role in shaping Gladstone’s future
Researchers created an atlas to identify cells most likely to be infected
The ALS Association recognized Steven Finkbeiner’s pioneering work and urgent focus to bring effective treatments to patients with ALS.
Studer was selected for his groundbreaking research in stem cell–based therapies for Parkinson’s disease
Gladstone’s English as a Second Language course has been helping researchers and trainees for nearly 20 years
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders